BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)

BioNTech SE has reported Interest & Investment Income for 8 years, with the latest figure at $115.9 million in Q4 2025.

• Quarterly Interest & Investment Income fell 34.32% year-over-year to $115.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $477.4 million (down 34.09% YoY) and the FY2025 annual result came in at $478.9 million, down 32.5% from the prior year.
• Interest & Investment Income advanced to $115.9 million in Q4 2025 per BNTX's latest filing, from $113.2 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $305.4 million in Q1 2022 and troughed at $361281.4 in Q2 2021.
• A 5-year average of $120.5 million and a median of $121.3 million in 2022 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2023: Interest & Investment Income soared 34013.31% in 2022, then plunged 71.07% in 2023.
• Over 5 years, Interest & Investment Income stood at $18.6 million in 2021, then soared by 112.29% to $39.6 million in 2022, then jumped by 340.86% to $174.5 million in 2023, then increased by 1.15% to $176.5 million in 2024, then sank by 34.32% to $115.9 million in 2025.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $115.9 million, $113.2 million, and $119.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.